JD HEALTH INTL LTD (8ZN) — Capital Reinvestment Ratio

Latest as of June 2023: 0.11x

JD HEALTH INTL LTD (8ZN) has a Capital Reinvestment Ratio of 0.11x as of June 2023, meaning it reinvests 0% of its operating cash flow (€184.04 Million) in capital expenditures (€19.75 Million). Check 8ZN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

€184.04 Million
EUR

Capital Expenditures

€19.75 Million
EUR

Data as of

Jun 2023
Most recent filing

JD HEALTH INTL LTD Capital Reinvestment Ratio (2019–2025)

This chart tracks JD HEALTH INTL LTD's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see 8ZN cash generation efficiency.

Annual Capital Reinvestment Ratio for JD HEALTH INTL LTD (2019–2025)

Year-by-year Capital Reinvestment Ratio for JD HEALTH INTL LTD from 2019 to 2025. See JD HEALTH INTL LTD free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.01x €10.17 Billion €151.01 Million ▲ +38.7%
2024 0.01x €4.33 Billion €46.35 Million ▼ -28.9%
2023 0.02x €4.60 Billion €69.33 Million ▲ +121.4%
2022 0.01x €5.91 Billion €40.16 Million ▼ -95.4%
2021 0.15x €3.43 Billion €502.21 Million ▲ +3349.6%
2020 0.00x €3.70 Billion €15.70 Million ▼ -66.5%
2019 0.01x €409.47 Million €5.19 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow